Literatur
- 1
NICE-SUGAR Study
Investigators .
Intensive versus conventional glucose
control in critically ill patients.
N Engl J Med.
2009;
360
1283-1297
- 2
Pittas A G, Siegel R D, Lau J.
Insulin therapy for critically ill hospitalized patients.
Arch Intern Med.
2004;
164
2005-2011
- 3
The Action to Control Cardiovascular
Risk in Diabetes Study Group .
Effects of intensive glucose
lowering in type 2 diabetes.
N Engl J Med.
2008;
358
2545-2559
- 4
Van den Berghe G, Wilmer A, Hermans G. et al .
Intensive insulin therapy in the medical
ICU.
N Engl J Med.
2006;
354
449-461
- 5
Van den Berghe G, Wouters P, Weekers F. et al .
Intensive insulin therapy in critically
ill patients.
N Engl J Med.
2001;
345
1359-1367
- 6
Wiener R S, Wiener D C, Larson R J.
Benefits and risks of tight glucose control
in critically ill adults.
JAMA.
2008;
300
933-944
Prof. Dr. Petra-Maria Schumm-Draeger
Klinik für Endokrinologie, Diabetologie
und Angiologie, Klinikum Bogenhausen, Städtische
Klinikum München GmbH
Englschalkinger Str. 77
81925 München
Telefon: 089/9270-2111
Fax: 089/9270-2116
